TY - CHAP M1 - Book, Section TI - Drug Use Disorders and Addiction A1 - O’Brien, Charles P. A2 - Brunton, Laurence L. A2 - Hilal-Dandan, Randa A2 - Knollmann, Björn C. PY - 2017 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e AB - AbbreviationsAIDS: acquired immune deficiency syndromeCDC: U.S. Centers for Disease Control and PreventionCNS: central nervous systemDA: dopamineDAT: dopamine transporterDEA: Drug Enforcement AgencyDMT:N, N-dimethyltryptamineDOM: dimethoxymethylamphetamineEEG: electroencephalogramFDA: U.S. Food and Drug AdministrationGABA: γ-aminobutyric acidGI: gastrointestinalGPCR: G protein–coupled receptor5HT: serotoninLSD: lysergic acid diethylamideMDA: methylenedioxyamphetamineMDMA: methylenedioxymethamphetamineMOR: μ opioid receptorNE: norepinephrineNMDA:N-methyl-D-aspartatePCP: phenycyclidineΔ-9-THC: Δ-9-tetrahydrocannabinol SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/04 UR - hemonc.mhmedical.com/content.aspx?aid=1162537356 ER -